<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940802-1-00017</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4702 -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;52.3 <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Who is eligible to apply for a grant? <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Persons eligible.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Any individual, corporation, public or private institution or agency, or other legal entity shall be eligible for a grant award, except: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1) An individual or entity which is otherwise ineligible for an award under applicable law or regulation (e.g., only Diabetes Eye Research Institutions are eligible for research project grants on eye care and diabetes under section 456 of the PHS Act); <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (2) Federal agencies or institutions, unless specifically authorized by law to receive the grant; <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (3) Individuals, corporations, institutions, agencies, and other entities during the period they are debarred or suspended from eligibility for Federal financial assistance (see 45 CFR part 76). <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (b)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Permissible activities within research projects.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Any project found by the Secretary to be a research project within the meaning of this part shall be eligible for a grant award. Eligible projects may consist of laboratory, clinical, population, field, statistical, basic, applied or other types of investigations, studies or experiments, or combinations thereof, and may either be limited to one, or a particular aspect of a problem or subject, or may consist of two or more related problems or subjects for concurrent or consecutive investigation and involving multiple disciplines, facilities and resources. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (c)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Preferences.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> In the award of grants for international research relating to the development and evaluation of vaccines and treatments for AIDS under section 2315 of the Act, preference shall be given to <!-- PJG 0012 frnewline --> (1) Activities conducted by, or in cooperation with, the World Health Organization and  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (2) With respect to activities in the Western Hemisphere, activities conducted by, or in cooperation with, the Pan American Health Organization or the World Health Organization. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> 6. Section 52.4 would be revised to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;52.4 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> How to apply for a grant? <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Each institution interested in applying for a grant under this part must submit an application at such time and in such form and manner as the Secretary may prescribe. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> 7. Section 52.6 would be amended as follows: <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> In paragraph (a) the first sentence would be revised to read as set forth below; paragraphs (b), (c), (d) and (e) would be redesignated (c), (d), (e) and (f), respectively; new paragraph (b) would be added, and paragraphs (c)(2) and (d) would be revised to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;52.6 <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Grant awards. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> (a) Within the limits of funds available for such purpose, the Secretary will award a grant to those applicants whose approved projects will in the Secretary's judgment best promote the purposes of the statute authorizing the grant and the regulations of this part.*&blank;*&blank;* <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (b)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Evaluation of unapproved drug treatments for AIDS.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Grants under section 2314 of the Act to support research relating to the evaluation of drug treatments for AIDS not approved by the Commissioner of the Food and Drug Administration, shall be subject to appropriate scientific and ethical guidelines established by the Secretary for each project, pursuant to section 2314(c) of the Act. In order to receive a grant, the applicant must agree to comply with those guidelines. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (c)  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> Notice of grant award. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (1) *&blank;*&blank;* <!-- PJG 0012 frnewline --> (2) Generally, the grant will initially be for one year and subsequent continuation awards will also be for one year at a time. A grantee must submit an application at the time and in the form and manner as the Secretary may prescribe to have support continued for each subsequent year. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (3) *&blank;*&blank;* <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> (d) Multiple or concurrent awards.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Whenever a research project involves a number of different but related problems, activities or disciplines which require evaluation by different groups, or whenever support for a project could be more effectively administered by separate handling of separate aspects of the project, the Secretary may evaluate, approve and make awards pursuant to two or more concurrent applications, each dealing with one or more specified aspects of the project. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=37 g=1 f=1 --> * * * * * <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 8. Section 52.8 would be revised to read as follows: <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=80 g=1 f=1 --> &sect;52.8 <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=89 g=1 f=1 --> Other HHS policies and regulations that apply. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Several other HHS policies and regulations apply to grants under this part. These include, but are not necessarily limited to: <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=15 g=1 f=1 --> 37 CFR part 401_Rights to inventions made by nonprofit organizations and small business firms under government grants, contracts, and cooperative agreements <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 42 CFR part 50, subpart A_Responsibility of PHS awardee and applicant institutions for dealing with and reporting possible misconduct in science <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 42 CFR part 50, subpart D_Public Health Service grant appeals procedure <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 45 CFR part 16_Procedures of the Departmental Grant Appeals Board <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 45 CFR part 46_Proteciton of human subjects <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            